Free Access
Med Sci (Paris)
Volume 26, Number 4, Avril 2010
Page(s) 435 - 438
Section Forum
Published online 15 April 2010
  1. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420 : 860–7. [Google Scholar]
  2. Littman AJ, Thornquist MD, White E, et al. Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control 2004; 15 : 819–27. [Google Scholar]
  3. Ardies CM. Inflammation as cause for scar cancers of the lung. Integr cancer ther 2003; 2 : 238–46. [Google Scholar]
  4. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5 : 749–59. [Google Scholar]
  5. Pikarsky E, Porat R, Stein I, et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431 : 461–466. [Google Scholar]
  6. He W, Liu Q, Wang L, et al. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 2007; 44 : 2850–9. [Google Scholar]
  7. Droemann D, Albrecht D, Gerdes J, et al. Human lung cancer cells express functionally active Toll-like receptor 9. Respir Res 2005; 6 : 1. [Google Scholar]
  8. Tsan MF. Toll-like receptors, inflammation and cancer. Semin Cancer Biol 2006; 16 : 32–7. [Google Scholar]
  9. Cherfils-Vicini J, Platonova S, Gillard M, et al. Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance. J Clin Invest 2010; 8 mars : pli 36551. doi : 10.1172/JCI 36551. [Google Scholar]
  10. Brevet Européen (demande déposée en août 2008): EP08305490. Methods for predicting the response to treatment and for treating cancer. Fridman WH, Cherfils-Vicini J, Cremer I. Extension PCT: PCT/EP2009/060555. [Google Scholar]
  11. Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004; 350 : 379–92. [Google Scholar]
  12. Dieu-Nosjean MC, Antoine M, Danel C, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008; 26 : 4410–7. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.